サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1753979

医薬品ファインケミカル市場レポート：タイプ、製品、サイズ、用途、地域別、2025～2033年

Pharmaceutical Fine Chemicals Market Report by Type, Product, Size, Application, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 150 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
医薬品ファインケミカル市場レポート：タイプ、製品、サイズ、用途、地域別、2025～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品ファインケミカルの世界市場規模は2024年に1,491億米ドルに達しました。IMARC Groupは、2025～2033年にかけての成長率（CAGR）は5.38%で、2033年には2,447億米ドルに達すると予測しています。

ファインケミカルとは、高価格で限られた量しか製造されない、純粋で複雑な化学品を指します。これらの化学品は、多段階のバッチ式バイオテクノロジー手法の支援を受けて、多目的プラントで生産されます。特殊化学品とは異なり、これらの物質は、その明確な機能特性と特定の分子特性に基づいて正確に蓄積されます。回収後、ファインケミカルは、ステアリン酸マグネシウムやゼラチンなど、いくつかの医薬化学製品を製造するための主剤、安定剤、溶剤として使用されます。現在、これらのファインケミカルは、プロプライエタリーとノンプロプライエタリーのバリエーションで市販されています。

医薬品ファインケミカル市場動向

不整脈、脳卒中、がん、冠動脈疾患など、さまざまな神経疾患や心血管疾患の有病率が、特に高齢者の間で高まっていることが、医薬ファインケミカル市場を成長へと向かわせる主要因の一つです。これに伴い、コロナウイルス感染症（COVID-19）やその他の疾患に対する新しいワクチン、医薬品、医薬品を導入するために、いくつかの国の政府機関によって実施された有利なイニシアチブは、ヘルスケア部門におけるこれらの医薬品の広範な採用をさらに促進しています。これが、市場のもう一つの成長促進要因となっています。さらに、医薬品を製造するための原料として医薬品ファインケミカルを利用するためのさまざまなガイドラインの施行が、品質基準を満たしつつ市場の成長に寄与しています。その他の要因としては、製薬産業の大幅な拡大、研究開発（R&D）活動への投資の増加、多くの疾患と利用可能な投薬オプションに関する消費者の意識の高まりなどがあり、世界全体で市場の明るい展望を生み出しています。

本レポートで扱う主要質問

  • 医薬品ファインケミカルの世界市場規模は？
  • 2025～2033年における世界の医薬品ファインケミカル市場の予想成長率は？
  • 医薬品ファインケミカルの世界市場を牽引する主要因は？
  • 医薬品ファインケミカルの世界市場におけるCOVID-19の影響は？
  • 医薬品ファインケミカルの世界市場におけるタイプによる区分は？
  • 医薬品ファインケミカルの世界市場における製品による区分は？
  • 医薬品ファインケミカルの世界市場におけるサイズによる区分は？
  • 医薬品ファインケミカルの世界市場における主要地域は？
  • 医薬品ファインケミカルの世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の医薬品ファインケミカル市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • プロプライエタリ
  • 非プロプライエタリ

第7章 市場内訳：製品別

  • 有効要素
  • 基本構成要素
  • 高度中間体

第8章 市場内訳：サイズ別

  • 大分子
  • 小分子

第9章 市場内訳：用途別

  • 心血管系
  • 神経
  • 腫瘍
  • 呼吸器
  • 胃腸
  • 筋骨格
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BASF SE
    • Borregaard ASA
    • CHEMADA Industries Ltd.（Turpaz）
    • Denisco Chemicals Pvt Ltd
    • Dupont De Nemours Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Koninklijke DSM N.V.
    • Lonza Group AG
    • Solvay S.A.
    • Syntor Fine Chemicals Ltd.（Aceto Corporation）
    • W. R. Grace and Co.（Standard Industries Inc.）
図表

List of Figures

  • Figure 1: Global: Pharmaceutical Fine Chemicals Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Fine Chemicals Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pharmaceutical Fine Chemicals Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Pharmaceutical Fine Chemicals Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Pharmaceutical Fine Chemicals Market: Breakup by Size (in %), 2024
  • Figure 7: Global: Pharmaceutical Fine Chemicals Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Pharmaceutical Fine Chemicals Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Pharmaceutical Fine Chemicals (Proprietary) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Pharmaceutical Fine Chemicals (Proprietary) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Pharmaceutical Fine Chemicals (Neurological) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Pharmaceutical Fine Chemicals (Neurological) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Pharmaceutical Fine Chemicals (Oncological) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Pharmaceutical Fine Chemicals (Oncological) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Pharmaceutical Fine Chemicals (Respiratory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Pharmaceutical Fine Chemicals (Respiratory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Pharmaceutical Fine Chemicals (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Pharmaceutical Fine Chemicals (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Pharmaceutical Fine Chemicals Industry: SWOT Analysis
  • Figure 87: Global: Pharmaceutical Fine Chemicals Industry: Value Chain Analysis
  • Figure 88: Global: Pharmaceutical Fine Chemicals Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Fine Chemicals Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Size (in Million USD), 2025-2033
  • Table 5: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Pharmaceutical Fine Chemicals Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Fine Chemicals Market: Key Players
目次
Product Code: SR112025A5910

The global pharmaceutical fine chemicals market size reached USD 149.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 244.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.38% during 2025-2033.

Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.

Pharmaceutical Fine Chemicals Market Trends:

The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.

Key Market Segmentation:

Breakup by Type:

  • Proprietary
  • Non-proprietary

Breakup by Product:

  • Active Ingredients
  • Basic Building Blocks
  • Advanced Intermediates

Breakup by Size:

  • Big Molecules
  • Small Molecules

Breakup by Application:

  • Cardiovascular
  • Neurological
  • Oncological
  • Respiratory
  • Gastrointestinal
  • Musculoskeletal
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).

Key Questions Answered in This Report

  • 1.How big is the global pharmaceutical fine chemicals market?
  • 2.What is the expected growth rate of the global pharmaceutical fine chemicals market during 2025-2033?
  • 3.What are the key factors driving the global pharmaceutical fine chemicals market?
  • 4.What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
  • 5.What is the breakup of the global pharmaceutical fine chemicals market based on the type?
  • 6.What is the breakup of the global pharmaceutical fine chemicals market based on the product?
  • 7.What is the breakup of the global pharmaceutical fine chemicals market based on the size?
  • 8.What are the key regions in the global pharmaceutical fine chemicals market?
  • 9.Who are the key players/companies in the global pharmaceutical fine chemicals market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Fine Chemicals Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proprietary
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proprietary
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Active Ingredients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Basic Building Blocks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Advanced Intermediates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Size

  • 8.1 Big Molecules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Small Molecules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Cardiovascular
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Neurological
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Oncological
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Respiratory
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Gastrointestinal
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Musculoskeletal
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Borregaard ASA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 CHEMADA Industries Ltd. (Turpaz)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Denisco Chemicals Pvt Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dupont De Nemours Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eastman Chemical Company
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Solvay S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Syntor Fine Chemicals Ltd. (Aceto Corporation)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 W. R. Grace and Co. (Standard Industries Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis